AI
HELP

AdvisorShares Investments’s Helus Pharma Inc. Common Stock HELP Stock Holding History

AdvisorShares Investments’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.93M Buy
292,711
+97,107
+50% +$486K 0.23% 52
2026
Q1 		$939K Buy
195,604
+97,546
+99% +$631K 0.17% 81
2025
Q4 		$802K Sell
98,058
-18,044
-16% -$116K 0.13% 92
2025
Q3 		$684K Buy
116,102
+27,719
+31% +$196K 0.11% 97
2025
Q2 		$742K Buy
88,383
+28,000
+46% +$204K 0.13% 85
2025
Q1 		$357K Buy
60,383
+9,732
+19% +$84.3K 0.07% 197
2024
Q4 		$447K Buy
50,651
+1,567
+3% +$15.9K 0.09% 156
2024
Q3 		$436K Sell
49,084
-1
-0% -$10 0.08% 183
2024
Q2 		$494K Buy
49,085
+5,800
+13% +$75.9K 0.09% 114
2024
Q1 		$680K Sell
43,285
-5,641
-12% -$81.5K 0.11% 74
2023
Q4 		$762K Sell
48,926
-2,401
-5% -$44.7K 0.18% 60
2023
Q3 		$1.04M Sell
51,327
-5,584
-10% -$82.2K 0.28% 40
2023
Q2 		$817K Sell
56,911
-3,114
-5% -$37.5K 0.23% 41
2023
Q1 		$878K Buy
60,025
+15,858
+36% +$257K 0.27% 42
2022
Q4 		$499K Buy
44,167
+6,287
+17% +$104K 0.14% 95
2022
Q3 		$697K Buy
37,880
+10,308
+37% +$279K 0.19% 85
2022
Q2 		$587K Buy
27,572
+3,711
+16% +$89.9K 0.16% 93
2022
Q1 		$741K Buy
23,861
+8,514
+55% +$311K 0.12% 97
2021
Q4 		$700K Buy
15,347
+12,922
+533% +$819K 0.08% 100
2021
Q3 		$202K Buy
+2,425
New +$212K 0.03% 141

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

AdvisorShares Investments's HELP Position: Q2 2026 in Review

AdvisorShares Investments increased its Helus Pharma Inc. Common Stock (HELP) stake by 50% in Q2 2026, buying an estimated $486K and bringing the position to 292,711 shares worth $1.93M. The position accounts for 0.23% of the portfolio, ranked #52.

AdvisorShares Investments first reported a position in HELP in Q3 2021 and has held it in 20 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • AdvisorShares Investments held 292,711 shares of Helus Pharma Inc. Common Stock worth $1.93M as of Q2 2026.
  • AdvisorShares Investments bought 97,107 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $486K.
  • Helus Pharma Inc. Common Stock made up 0.23% of AdvisorShares Investments's portfolio in Q2 2026, its #52 holding.
  • AdvisorShares Investments first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 20 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on AdvisorShares Investments's 13F filing for Q2 2026, filed 11 Aug 2026.